InsiderTrades

Form 4 for NBIX NEUROCRINE BIOSCIENCES INC

Accepted 2024-05-21 00:00:00 ET · period of report 2024-05-17 · accession 0000914475-24-000136 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-05-21 2024-05-17 NBIX POPS RICHARD F Dir M - OptEx $0.00 +4,199 33.7K +14% $0
D 2024-05-21 2024-05-17 NBIX POPS RICHARD F Dir S - Sale+OE $141.84 -2,100 31.6K -6% -$297.9K
D 2024-05-21 2024-05-17 NBIX POPS RICHARD F Dir M - OptEx $0.00 -4,199 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-05-17 M A 4,199 $0.00 33,711 D — —
2 Common Common Stock 2024-05-17 S D 2,100 $141.84 31,611 D — — (F2) Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $140.80 to $142.71. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range
3 Derivative Restricted Stock Unit 2024-05-17 M D 4,199 $0.00 0 D — · — to — 4,199 Common Stock (F3) Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting. (F4) This RSU award was granted to the Reporting Person on May 17, 2023 and is fully vested.